TUPELO — For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough solution. Larry Ferguson, 77, of Pontotoc, is among those whose ...

ResMed and Inspire Medical Systems stocks tumbled Monday ... In comparison, 51.5% of patients treated with a CPAP machine met the bar for disease resolution. Tirzepatide patients also had a ...

Stifel Nicolaus analyst Jonathan Block maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

For over 20 years, I have relied on a CPAP machine to manage my sleep apnea—a life-threatening condition that, if left untreated, can cause serious complications, including death during sleep.

Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for people with sleep apnea. Host Dr. Justin Clark and his guests ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...